Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01483079 · ClinicalTrials.gov registry record
Post-Discharge Growth of Infants Who Received Donor Human Milk Products in the Neonatal Intensive Care Unit (NICU)
A clinical trial of Prematurity, sponsored by Baylor College of Medicine.
- Active
- Registry status
- 51
- Enrollment target
- 1
- Study location
NCT01483079: Active study of Prematurity, sponsored by Baylor College of Medicine.
NCT01483079 is a study of Prematurity that is active but no longer recruiting, run by Baylor College of Medicine. The registered enrollment target is 51 participants, below the 209-participant average among 21 other Prematurity trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01483079, a study of Prematurity, is active but no longer recruiting, sponsored by Baylor College of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
Human milk feeding is associated with great benefits to the health and development of infants, especially in premature infants. Some mothers are unable or unwilling to provide breast milk to their infant. The use of donor human milk products for very low birth weight infants as an alternative to cow milk has risen dramatically in the past year. Purpose: To evaluate post-discharge growth and neurodevelopment of infants less than or equal to 1250 grams birth weight receiving an exclusive human milk protein diet.
Primary Outcome
Per the protocol procedures, growth and development will be assessed at each study visit.
Conditions Studied
Study Locations (1)
Texas
- Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2011-12 |
| Est. Completion | 2026-12 |
What the registry record for NCT01483079 still lists
NCT01483079 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 209-participant average among 21 other Prematurity trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Prematurity appearing as the primary indexed condition, and to 0 interventions.
NCT01483079 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01483079 about?
NCT01483079 is a clinical study titled "Post-Discharge Growth of Infants Who Received Donor Human Milk Products in the Neonatal Intensive Care Unit (NICU)". Human milk feeding is associated with great benefits to the health and development of infants, especially in premature infants. Some mothers are unable or unwilling to provide breast milk to their infant. The use of donor human milk products for very low birth weight infants as an alternative to cow...
What is the current status of trial NCT01483079?
This trial is currently active not recruiting. The enrollment target is 51 participants. The study started on 2011-12. Estimated completion is 2026-12.
What conditions does trial NCT01483079 study?
This clinical trial studies the following conditions: Prematurity.
Who is sponsoring clinical trial NCT01483079?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01483079 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prematurity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01483079's enrollment target sits among peer trials
51 19th of 21 higher than 2 of 21 other Prematurity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prematurity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
RECRUITING · Phase 2
-
The Impact of Music Medicine on Preterm Brain Development and Behavior
RECRUITING · NA
-
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
RECRUITING · NA
-
Nourishing Tomorrow: Role of Medically Tailored Groceries in Addressing Food Insecurity During Pregnancy
RECRUITING · NA
-
Evaluating Wearable Smart Sensors for Continuous Measurement of Vital Signs in ICU Patients
RECRUITING
-
Maternal Stress, Milk Composition, and Preterm Neurodevelopment
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia